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Abstract
Background: Several neuraxial techniques have demonstrated effective post-cesarean section analgesia. According to
previous reports, it is likely that patient-controlled epidural analgesia (PCEA) without opioids is inferior to intrathecal
morphine (IM) alone for post-cesarean section analgesia. However, little is known whether adding PCEA to IM is effective
or not. The aim of this study was to compare post-cesarean section analgesia between IM with PCEA and IM alone.
Methods: Fifty patients undergoing elective cesarean section were enrolled in this prospective randomized study.
Patients were randomized to one of two groups: IM group and IM + PCEA group. All patients received spinal
anesthesia with 12mg of 0.5% hyperbaric bupivacaine, 10 μg of fentanyl, and 150 μg of morphine. Patients in IM +
PCEA group received epidural catheterization through Th11–12 or Th12-L1 before spinal anesthesia and PCEA (basal
0.167% levobupivacaine infusion rate of 6 mL/h, bolus dose of 3 mL in lockout interval of 30min) was commenced at
the end of surgery. A numerical rating scale (NRS) at rest and on movement at 4,8,12,24,48 h after the intrathecal
administration of morphine were recorded. In addition, we recorded the incidence of delayed ambulation and the
number of patients who requested rescue analgesics. We examined NRS using Bonferroni’s multiple comparison test
following repeated measures analysis of variance; p < 0.05 was considered as statistically significant.
Results: Twenty-three patients in each group were finally analyzed. Mean NRS at rest was significantly higher in IM group
than in IM + PCEA group at 4 (2.7 vs 0.6), 8 (2.2 vs 0.6), and 12 h (2.5 vs 0.7), and NRS during mobilization was significantly
higher in IM group than in IM + PCEA group at 4 (4.9 vs 1.5), 8 (4.8 vs 1.9), 12 (4.9 vs 2), and 24 h (5.7 vs 3.5). The number
of patients who required rescue analgesics during the first 24 h was significantly higher in IM group compared to IM +
PCEA group. No significant difference was observed between the groups in incidence of delayed ambulation.
Conclusions: The combined use of PCEA with IM provided better post-cesarean section analgesia compared to IM alone.
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Background
Several neuraxial techniques have demonstrated effective
postoperative analgesia following cesarean section [1–4].
Intrathecal or epidural morphine and patient-controlled
epidural anesthesia (PCEA) are generally used for post-
cesarean section analgesia. One study reported that
intrathecal morphine alone was superior to epidural
morphine alone or PCEA without opioids for postopera-
tive analgesia following cesarean section [1]. Both intra-
thecal and epidural morphine are reported to be
effective for post-cesarean section analgesia [5, 6], how-
ever, it is unknown if there is a meaningful difference
between the route through which a single dose of neur-
axial morphine is administered. Another study con-
cluded that the combined use of intrathecal morphine
and PCEA improved post-cesarean section analgesia
compared to PCEA without opioids [2]. Based on the lit-
erature and one retrospective study [7], it is likely that
PCEA without opioids is inferior to intrathecal morphine
alone for post-cesarean section analgesia. In other
words, performing PCEA without opioids may not be a
reason to omit intrathecal morphine. However, little is
known whether adding epidural anesthesia to intrathecal
morphine is effective or not. We hypothesized that the
combined use of PCEA and intrathecal morphine may
have an advantage in post-cesarean section analgesia
compared to intrathecal morphine alone.
Methods
This study was registered in the University Hospital
Medical Information Network under registration num-
ber UMIN000032475 with approval from the hospital’s
ethics committee. This study adheres the applicable
CONSORT guidelines. Healthy pregnant women sched-
uled for cesarean section at Kushiro Red Cross Hospital
(Hokkaido, Japan) were enrolled in this study. Written
informed consent was obtained from all the patients.
We included patients of the American Society of Anes-
thesiologists physical status classification scale I and II.
We excluded patients with contraindications for spinal
or epidural anesthesia due to hemodynamic, infectious,
hemostatic, neurological statuses, and medication use. In
addition, we excluded cases of which we were unable to
obtain informed consent such as extremely emergent
cesarean sections, and cases of which general anesthesia
was selected for reasons such as urgency or predicted
massive hemorrhage. Using sealed envelopes, patients
were randomly divided into two groups: Group IM
(intrathecal morphine alone) and Group IM + PCEA
(intrathecal morphine combined with PCEA).
Patients in the IM+ PCEA group received epidural
catheterization prior to spinal anesthesia. A 19-gauge epi-
dural catheter with an 18-gauge epidural Tuohy needle was
inserted 5 cm through the Th11–12 or Th12-L1 vertebral
interspace. All patients received spinal anesthesia at the
L2–3 or L3–4 vertebral interspace with a 25-gauge Quincke
spinal needle (TOP Corp., Tokyo, Japan) with 0.5% hyper-
baric bupivacaine (12mg), fentanyl (10 mcg), and morphine
(150 mcg) administered. Prior to spinal anesthesia, rapid in-
fusion of 6% hydroxyethyl starch 130/0.4 (Voluven, Frese-
nius Kabi Japan, Tokyo, Japan) and a total of 1000ml was
administered during surgery. Systolic blood pressure was
maintained above 100mmHg using boluses of phenyleph-
rine 100mcg. A bolus of droperidol 1.25mg was adminis-
tered to treat intraoperative nausea and vomiting when
necessary. In the IM+ PCEA group, continuous epidural
infusion of 0.167% levobupivacaine using disposable PCEA
infusers (Smiths Medical Japan, Tokyo, Japan) were com-
menced at the end of surgery and ceased after 24 h. The
PCEA settings were basal infusion rate of 6mL/h, patient-
controlled analgesia (PCA) demand dose of 3mL, and lock-
out interval of 30min. To confirm the effect of PCEA, cold
sensory blockade was assessed prior to removal of the epi-
dural catheter. We excluded patients with insufficient or
unilateral sensory block from the analysis. In the IM+
PCEA group, the epidural catheter was removed 24 h after
intrathecal administration of morphine but prior to ambu-
lation. All patients began ambulation 24 h after intrathecal
administration of morphine. Oxygen saturation was moni-
tored for 24 h after surgery for concerns of respiratory de-
pression potentially related to morphine.
We recorded postoperative pain scores using an 11-
point verbal score numerical rating scale (NRS) ranging
from 0 as no pain to 10 as worst imaginable pain, at rest
and on movement (sitting in an upright position and
movement of lower extremities) at 4, 8, 12, 24, 48 h after
intrathecal administration of morphine. In addition, we
assessed the intensity of motor blockade of lower ex-
tremities according to the Bromage score [8] (score 1 =
free movement of legs and feet; score 2 = just able to flex
knees with free movement of feet; score 3 = unable to
flex knees, but with free movement of feet; and score
4 = unable to move legs or feet). Inadequate analgesia
was managed with 50mg diclofenac suppository or a
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drip infusion of 50 mg flurbiprofen axetil for the first 24
h. Morphine-induced side effects including pruritus and
postoperative nausea and vomiting (PONV) were treated
with 25 mg of hydroxyzine hydrochloride drip infusion
and 10mg of intravenous metoclopramide infusion, re-
spectively. All data were collected by an investigator
who was not involved in providing anesthesia. In
addition, patients were asked to rate their satisfaction
with analgesia before discharge as follows; 5:completely
satisfied, 4:satisfied, 3:fair, 2:unsatisfied, 1:completely
unsatisfied.
The primary outcome of this study was postoperative
pain as measured by NRS at 12 h after intrathecal ad-
ministration of morphine during mobilization. Second-
ary outcomes were NRS at 12 h after intrathecal
administration of morphine at rest, NRS and Bromage
score at 4, 8, 24, 48 h after intrathecal administration of
morphine at rest and during mobilization, the number
of patients who requested rescue analgesics, the number
of requests for rescue analgesics per patient, the interval
time before the first request of rescue analgesics, the in-
cidence of delayed ambulation, the incidence of re-
quested treatment for pruritus and PONV during the
first 24 h after intrathecal administration of morphine,
and patient satisfaction before discharge.
Statistical analysis
The sample size calculation of 21 patients for each group
to provide an α value of 0.05 and a β value of 0.1, was
based on NRS of 10 previous post-cesarean section pa-
tients who were not included in the final analysis (5 pa-
tients who received intrathecal morphine and 5 patients
who received both intrathecal morphine and PCEA) dur-
ing mobilization at 12 h after intrathecal administration
of morphine. We adjusted our sample size of 25 patients
for each group for anticipated dropouts.
Results are expressed as mean ± standard deviation
(SD), unless stated otherwise. We examined NRS and
Bromage scores using Bonferroni’s multiple comparison
test following repeated measures analysis of variance.
Differences between groups were compared using un-
paired t-test for patient characteristics and analgesic sat-
isfaction, and Mann-Whitney U test for rescue
analgesics and morphine-induced side effects. For cat-
egorical data, we used Fisher’s exact test. All statistical
analyses were performed using GraphPad Prism® version
7.03 (GraphPad Software, Inc., La Jolla, CA) and a P-
value of < 0.05 was considered statistically significant.
Results
Fifty pregnant women (aged 20–45 years) scheduled for
cesarean section were enrolled in this study between
January 2017 and April 2018. The CONSORT diagram
is showed in Fig. 1. We excluded 2 patients in IM group
due to use of rescue analgesic during the surgery and 2
patients in IM + PCEA group due to insufficient effect of
PCEA and early removal of epidural catheter. Finally, 23
patients in each group were analyzed. Patient character-
istics and intraoperative data were comparable among
the groups (Table 1). Twelve patients in the IM group
and 11 patients in the IM + PCEA group used antiemetic
drugs during surgery.
NRS obtained during the first 48 h are shown in Fig. 2.
Mean NRS at rest (Fig. 2a) was significantly higher in
IM group than in IM + PCEA group at 4 (2.7 vs 0.6), 8
(2.2 vs 0.6), and 12 h (2.5 vs 0.7), and NRS during
mobilization (Fig. 2b) was significantly higher in IM
group than in IM + PCEA group at 4 (4.9 vs 1.5), 8 (4.8
vs 1.9), 12 (4.9 vs 2), and 24 h (5.7 vs 3.5). In IM + PCEA
group, 6 out of 23 patients (26.1%) used PCA after sur-
gery, and the frequency of use of PCA was 0.78 ± 1.86
(mean ± SD).
With respect to requests for rescue analgesics, signifi-
cant differences were observed among the two groups
(Fig. 3). The number of patients who required rescue an-
algesics during the first 24 h was 18 (78.3%) in IM group,
and 7 (30.4%) in IM + PCEA group (Fig. 3a). The num-
ber of requests for rescue analgesics per patient was also
significantly higher in IM group (1.22 ± 0.80) than in
IM + PCEA group (0.3 ± 0.47) (Fig. 3b). The interval time
before the first request for rescue analgesics in IM +
PCEA group (1254 ± 120 min) was significantly higher
than IM group (521 ± 421 min) (Fig. 3c).
Three patients required treatment for pruritus in IM
group and 2 in IM + PCEA group. One patient in IM
group requested treatment for PONV. The difference
among the groups was not statistically significant for
morphine induced side effects.
There were no significant differences in Bromage
scores during the first 48 h between two groups
(Fig. 4). All patients were evaluated as 1 in Bromage
score from 24 h after intrathecal administration of
morphine. Ambulation was delayed for approximately
24 h in one patient in IM group due to postoperative
pain. Two patients in IM + PCEA group experienced
delayed ambulation for approximately 1 and 6 h, re-
spectively, due to weakness of lower extremities.
There were no patients who experienced neurological
complications or respiratory depression. All patients
discharged from the hospital on day 7 after the sur-
gery as scheduled. We obtained patient satisfaction
score from 89% of the participants (21/23 in IM
group and 20/23 in IM + PCEA group). There was no
significant difference in patient satisfaction score be-
tween IM group (3.57 ± 1.36) and IM + PCEA group
(4.23 ± 0.73) (p = 0.0651). Although no patient gave
satisfaction score of 1 in IM + PCEA group, three pa-
tients in IM group scored 1.
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Discussion
By analyzing 46 patients scheduled for cesarean delivery
in this prospective randomized study, we found that the
combined use of PCEA and intrathecal morphine pro-
vides better post-cesarean section analgesia in the first
12 h at rest and in the first 24 h at movement compared
to intrathecal morphine alone. In addition, although no
significant difference in patient satisfaction score be-
tween IM group and IM + PCEA group was observed, a
trend of higher satisfaction was seen in IM + PCEA
group. To the best of our knowledge, this is the first
study to compare intrathecal morphine with PCEA and
intrathecal morphine alone. Similarly to our results,
when focusing on the advantages of PCEA, a previous
study concluded that the combined use of intrathecal
morphine and PCEA improved post-cesarean section an-
algesia compared to PCEA without opioids [2]. Another
study reported that intrathecal morphine alone was su-
perior to epidural morphine alone or PCEA without opi-
oids [1]. Accordingly, PCEA alone is likely to be inferior
to intrathecal morphine alone for post-cesarean section
analgesia. While the literature showed that intrathecal
morphine provided better post-cesarean section anal-
gesia compared to epidural morphine or PCEA without
opioids [1], the pain scores during mobilization in the
IM group in our study were similar to the present study.
Fig. 1 CONSORT diagram
Table 1 Patient characteristics and intraoperative data
IM group (n = 23) IM + PCEA group (n = 23) P value
Age (years) 33.30 ± 5.46 32.74 ± 4.98 0.7155
Height (cm) 157.87 ± 6.27 158.00 ± 5.89 0.9423
Weight (kg) 65.48 ± 10.20 64.65 ± 7.84 0.7596
Duration of surgery (minutes) 53.48 ± 10.30 51.13 ± 9.60 0.4281
Previous history of caesarean section 13 (56.5) 14 (60.9) > 0.9999
ASA physical status I/II 12 (52.2)/11 (47.8) 16 (69.6)/7 (30.4) 0.3651
Results are expressed as mean ± SD or as n (%). IM Intrathecal morphine, IM + PCEA Intrathecal morphine combined with patient-controlled epidural anesthesia,
ASA American Society of Anesthesiologists
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Therefore, intrathecal morphine alone may not be the
best post-cesarean section analgesia. Moreover, previous
studies have demonstrated that the suitable target for
optimal analgesia is NRS score of below 3–3.3/10 and
reductions in pain scores of 30–40% [9–13]. Therefore,
despite the statistical differences, postoperative analgesia
at rest seems to be sufficient in both IM group and IM +
PCEA group. By contrast, postoperative analgesia during
mobilization in IM group seems to be insufficient (mean
NRS range 4.8–5.7/10) and additional thoracic PCEA
(IM + PCEA group) provided clinically meaningful re-
duction (reduction to mean NRS range 1.5–3.5/10) in
pain scores and optimal analgesia.
High quality post-cesarean section analgesia is crucial
for postoperative recovery, as patients are recovering
from major abdominal surgery while breastfeeding and
caring for a newborn [14, 15]. To provide adequate post-
cesarean section analgesia, clinical management guide-
lines for obstetrician-gynecologists recommends a multi-
modal approach in which systematic opioids can be
reduced [16]. In guidelines of Enhanced Recovery After
Surgery (ERAS) Society, thoracic epidural analgesia is an
alternative to intrathecal morphine for post-open general
gynecologic surgery analgesia [17]. Further, despite the
benefit in analgesia, several risks of adding thoracic epi-
dural anesthesia should be taken into consideration.
First, patients will receive needle puncture twice to per-
form lumbar spinal and thoracic epidural anesthesia.
Second, use of a combined lumbar epidural and spinal
technique will save an additional procedure, however,
lumbar epidural analgesia may increase motor blockade
which can contribute to delay in ambulation. In the
present study, all patients in IM + PCEA group were
evaluated as 1 on Bromage score, indicating free move-
ment of legs and feet, with two patients (8.7%) experien-
cing delayed ambulation. The low incidence of delayed
ambulation may be linked to the level of placement of
the epidural catheter, which in the present study was the
lower thoracic vertebral interspace (Th11–12 or Th12-
L1). While motor blockade during thoracic epidural an-
algesia has been reported to be 6.7% at 24 h after
cesarean section [2], the incidence of motor blockade
Fig. 2 Numerical rating scale (NRS) during the first 48 h after intrathecal administration of morphine at rest and at movement. a. NRS at rest for
the first 48 h after intrathecal administration of morphine. b. NRS at movement for the first 48 h after intrathecal administration of morphine.
*P<0.01. IM = intrathecal morphine. IM + PCEA = intrathecal morphine combined with patient-controlled epidural anesthesia
Fig. 3 Requests for rescue analgesics during the first 24 h after intrathecal administration of morphine. a. Percentage of patients who requested
rescue analgesics. b. Number of requests for rescue analgesics per patient. P<0.0001. c. Interval time (minutes) before the first request for rescue
analgesics. P = 0.0005. IM = intrathecal morphine. IM + PCEA = intrathecal morphine combined with patient-controlled epidural anesthesia
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was shown to be 26% at 12 h after cesarean section dur-
ing continuous epidural infusion via L2–3 or L3–4 ver-
tebral interspace in prior studies [18]. Therefore, lumbar
epidural analgesia may increase the risk of motor block-
ade compared to thoracic epidural analgesia. Further-
more, it is known that adequate postoperative analgesia
is necessary for early ambulation in addition to recovery
of the motor function [19]. Likewise, one patient (4.3%)
in the IM group (who did not receive epidural
anesthesia) experienced delayed ambulation for approxi-
mately 24 h due to postoperative pain. Third, neuro-
logical complications are a rare but serious complication
associated with epidural anesthesia. Although there were
no patients with neurological complications in our study,
previous literature has reported the incidence of per-
manent neurological injury after epidural anesthesia as
0–7.6:1000 [20].
In addition, the choice and concentration of epidural
local anesthetic play an important role in post-cesarean
section analgesia and early ambulation. The choice of
local anesthetic usually depends on the speed of onset
required for the particular clinical situation. Epidural
local anesthetics commonly used for cesarean section
analgesia include lidocaine, bupivacaine, ropivacaine,
and chloroprocaine. Previous studies have used 0.1 to
0.2% ropivacaine or levobupivacaine for PCEA following
cesarean section [1, 2, 4, 21]. One study comparing
0.15% of plain ropivacaine and levobupivacaine for post-
cesarean section PCEA showed no significant differences
regarding postoperative analgesic efficacy and motor
weakness [4]. Another study which compared low con-
centration (0.15%) and high concentration (0.5%) levo-
bupivacaine for postoperative epidural analgesia after
major abdominal surgery reported that there were no
significant differences in analgesic effect with consistent
low motor blockade [22]. Therefore, low concentrated
levobupivacaine may be a potential alternative for ropi-
vacaine. In the present study we chose 0.167% levobupi-
vacaine as literature on levobupivacaine for post-
cesarean section PCEA was limited. The present study
showing low NRS scores without motor weakness in
IM + PCEA group supports that low concentrated levo-
bupivacaine may be optimal for post-cesarean section
PCEA.
The study has several potential limitations. First, al-
though patients were randomly divided into two groups,
PCEA did not allow a full blinding. However, the data
was collected by an investigator who was not involved in
providing anesthesia. Another method to minimize per-
formance bias is to compare IM + PCEA with levobupi-
vacaine versus IM + PCEA with saline alone as control
group, however, we were unable to conduct this for eth-
ical concerns. Second, only elective cesarean sections
were included in our study as we were unable to obtain
informed consent in extremely emergent cesarean sec-
tions. This may limit the generalizability of our infer-
ences to more severe cases. However, our findings
remain highly relevant to the majority of the population
who receive cesarean sections. Third, scheduled acet-
aminophen and/or non-steroidal anti-inflammatory
drugs (NSAIDs) were not used in our study. Scheduled
acetaminophen and/or NSAIDs is a less invasive form of
multimodal pain control compared to epidural
anesthesia and previously reported to improve post-
cesarean section analgesia [23, 24]. If the scheduled acet-
aminophen and/or NSAIDs were used in this study, it
Fig. 4 Bromage score of postoperative pain during the first 48 h after intrathecal administration of morphine. Bromage score: score 1 = free
movement of legs and feet; score 2 = just able to flex knees with free movement of feet; score 3 = unable to flex knees, but with free movement
of feet; and score 4 = unable to move legs or feet. IM = intrathecal morphine. IM + PCEA = intrathecal morphine combined with patient-controlled
epidural anesthesia
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might decrease the impact of PCEA. Forth, patients were
not allowed to ambulate with the epidural in place and the
thoracic epidural catheter was removed in 24 h after intra-
thecal administration of morphine. We speculate that a
thoracic PCEA might be beneficial in the setting of a lon-
ger period of infusion and patients being permitted to am-
bulate with the epidural catheter in place.
Conclusions
A combined use of PCEA and spinal anesthesia with intra-
thecal morphine provided better postoperative analgesia
following cesarean section without delay in ambulation
compared to single shot spinal anesthesia with intrathecal
morphine alone. Although there are several risks that re-
quire consideration, thoracic epidural catheterization and
24 h of PCEA in addition to intrathecal morphine may be
a reasonable option to improve post-cesarean section an-
algesia especially during mobilization.
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